Serum Institute of India on Tuesday said it has never exported vaccines at the cost of the people in India and remains committed to support the vaccination drive in the country. In the past few days,...

What’s up exactly with India’s vaccine prince, Adar Poonawalla? Last Sunday, the Serum Institute chief executive tweeted he’d be back in India “in a few days” after stirr...

The 40-year-old Serum Institute boss triggered a Twitter storm after he told the Times, London, he had flown to Britain just before it banned travellers from India and that he planned an “e...

“They are saying if you don’t give us the vaccine it’s not going to be good….It’s not foul language. It’s the tone. It’s the implication of what they might d...

...

Serum Institute of India's CEO Adar Poonawalla has been accorded 'Y' category security across India by the CRPF in view of "potential threats" to the businessman, involved in the...

Serum Institute of India (SII) -- the maker of the most used COVID-19 vaccine in the country -- on Wednesday announced a cut in price of the jab it plans to sell to states to Rs 300 per dose from the ...

  Adar Poonawalla, CEO of vaccine major Serum Institute of India (SII), on Sunday urged other countries to be patient as they wait for the supplies of COVID-19 vaccine, Covishield, as the compan...

Adar Poonawalla, set to acquire Magma Fincorp (MFL), on Thursday said the deal had caused a change in his plans for the finance sector: Poonawalla Finance his current non-banking finance company (NBFC...

Vaccine king Adar Poonawalla is acquiring a controlling stake in Magma Fincorp Ltd (MFL). Poonawalla’s Rising Sun Holdings will hold 60 per cent in Magma Fincorp following a preferential issue o...